Galapagos NV Company Description
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe.
The company’s pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma.
The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.
![Galapagos NV logo](https://img.stockanalysis.com/logos1/AS/GLPG.png)
Country | Belgium |
Founded | 1999 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 683 |
CEO | Paulus Stoffels |
Contact Details
Address: Generaal De Wittelaan L11 A3 Mechelen, 2800 Belgium | |
Phone | 32 1 534 29 00 |
Website | glpg.com |
Stock Details
Ticker Symbol | GLPG |
Exchange | Euronext Amsterdam |
Fiscal Year | January - December |
Reporting Currency | EUR |
ISIN Number | BE0003818359 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Dr. Paulus A. Stoffels M.D., Ph.D. | Chief Executive Officer, Chairman, Interim Head of Research & Development |
Thad Huston | Executive Vice President, Chief Financial Officer and Chief Operating Officer |
Sofie Van Gijsel | Head of Investor Relations |
Valeria Cnossen | Executive Vice President and General Counsel |
Marieke Vermeersch | Head of Corporate Communication |
Annelies Missotten | Executive Vice President and Chief Human Resources Officer |
Ellen Van Der Aar | Head of Development |
Philippe Alen M.B.A., Ph.D., Pharm.D. | Senior Vice President and Head of Business Development |
Dirk De Naeyer | Head of Development Operations |
Alice Dietrich | Head of Medical Affairs |